Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ICCC
ICCC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ICCC News
NetSTREIT and ImmuCell Executives Increase Stock Holdings
Jun 22 2026
NASDAQ.COM
ImmuCell Reports Record Q1 2026 Earnings with $10M Revenue
May 15 2026
seekingalpha
ImmuCell Reports Strong Q1 Earnings with 28.4% Revenue Growth
May 14 2026
seekingalpha
ImmuCell Appoints New Board Members to Enhance Strategy
Apr 13 2026
Newsfilter
ImmuCell Q1 Sales Surge 28.4% Driven by Tri-Shield Demand
Apr 09 2026
seekingalpha
ImmuCell Reports 28.4% Revenue Growth in Q1 2026
Apr 09 2026
NASDAQ.COM
ImmuCell Reports 28.4% Sales Growth in Q1 2026
Apr 08 2026
seekingalpha
ImmuCell Corporation Q4 2025 Earnings Call Highlights
Mar 05 2026
seekingalpha
ImmuCell Reports Q4 2025 Financial Results
Mar 04 2026
seekingalpha
ImmuCell Corporation Schedules Financial Results Conference Call
Feb 18 2026
Newsfilter
ImmuCell Reports $27.6M Sales in 2025, Significant Growth in Tri-Shield®
Jan 08 2026
Globenewswire
ImmuCell Shifts Focus to First Defense Product Line Ahead of Q4 Sales Call
Jan 07 2026
Globenewswire
ImmuCell Pauses Re-Tain Investment, Focuses on First Defense Expansion
Dec 26 2025
Benzinga
ImmuCell Pauses Re-Tain® Investment, Expands First Defense® Sales Force by 50%
Dec 26 2025
Newsfilter
AbbVie Launches New Immunology Drugs, Stock Up 31.6% Over Last Year
Dec 26 2025
NASDAQ.COM
ImmuCell Pauses Re-Tain® Investment, Expands First Defense® Sales Force by 50%
Dec 24 2025
Globenewswire
Show More News
